BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2430476)

  • 1. Carcinoma of the prostate with atypical immunohistological features. Clinical and histologic correlates.
    Feiner HD; Gonzalez R
    Am J Surg Pathol; 1986 Nov; 10(11):765-70. PubMed ID: 2430476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
    Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
    Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical localization of prostate-specific acid phosphatase and prostate-specific antigen in stage A2 adenocarcinoma of the prostate: prognostic implications.
    Epstein JI; Eggleston JC
    Hum Pathol; 1984 Sep; 15(9):853-9. PubMed ID: 6381284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial polyps of the prostatic urethra. A light-microscopic and immunohistochemical study.
    Walker AN; Mills SE; Fechner RE; Perry JM
    Am J Surg Pathol; 1983 Jun; 7(4):351-6. PubMed ID: 6191587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the prostate with endometrioid features. A light microscopic and immunohistochemical study of ten cases.
    Epstein JI; Woodruff JM
    Cancer; 1986 Jan; 57(1):111-9. PubMed ID: 2416422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoperoxidase localization of prostatic acid phosphatase, prostate-specific antigen and gamma seminoprotein in primary and metastatic prostatic carcinoma].
    Yamaguchi K; Sumiya H; Fuse H; Ito H; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1986 May; 77(5):786-90. PubMed ID: 2427766
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
    Mai KT; Yazdi HM; Farmer J
    Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic prostatic carcinoma to supradiaphragmatic lymph nodes. A clinicopathologic and immunohistochemical study.
    Cho KR; Epstein JI
    Am J Surg Pathol; 1987 Jun; 11(6):457-63. PubMed ID: 2438955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic origin of tumors. An immunohistochemical study.
    Nadji M; Tabei SZ; Castro A; Chu TM; Morales AR
    Am J Clin Pathol; 1980 Jun; 73(6):735-9. PubMed ID: 6156593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoperoxidase localization of prostatic antigens. Comparison of primary and metastatic sites.
    Stein BS; Vangore S; Petersen RO
    Urology; 1984 Aug; 24(2):146-52. PubMed ID: 6205496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology of carcinoma of the prostate.
    Mostofi FK; Davis CJ; Sesterhenn IA
    Cancer; 1992 Jul; 70(1 Suppl):235-53. PubMed ID: 1376194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Argyrophilic prostatic carcinoma. Case report with literature review on prostatic carcinoid and "carcinoid-like" prostatic carcinoma.
    Almagro UA
    Cancer; 1985 Feb; 55(3):608-14. PubMed ID: 2578089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostatic carcinoma metastatic to bone: sensitivity and specificity of prostate-specific antigen and prostatic acid phosphatase in decalcified material.
    Shah NT; Tuttle SE; Strobel SL; Gandhi L
    J Surg Oncol; 1985 Aug; 29(4):265-8. PubMed ID: 2417056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reliability and use of prostate-specific antigen in the management of patients with prostatic cancer].
    Hübler J; Jávor A
    Orv Hetil; 1993 Jul; 134(28):1529-32. PubMed ID: 7688112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Endometrial' adenocarcinoma of the prostatic urethra arising in a villous polyp. A light microscopic and immunoperoxidase study.
    Walker AN; Mills SE; Fechner RE; Perry JM
    Arch Pathol Lab Med; 1982 Nov; 106(12):624-7. PubMed ID: 6182857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic adenoma of the prostatic urethra involving the prostate gland: a clinicopathologic and immunohistochemical study of eight cases.
    Malpica A; Ro JY; Troncoso P; Ordoñez NG; Amin MB; Ayala AG
    Hum Pathol; 1994 Apr; 25(4):390-5. PubMed ID: 7512941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases.
    Osunkoya AO; Epstein JI
    Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary adenocarcinomas of the prostate. An immunohistochemical study.
    Kuhajda FP; Gipson T; Mendelsohn G
    Cancer; 1984 Oct; 54(7):1328-32. PubMed ID: 6205741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A major solid undifferentiated carcinoma pattern correlates with tumour progression in locally advanced prostatic carcinoma.
    Gaffney EF; O'Sullivan SN; O'Brien A
    Histopathology; 1992 Sep; 21(3):249-55. PubMed ID: 1398521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of poorly differentiated prostatic tumors to staining for prostate specific antigen and prostatic acid phosphatase: a comparative study.
    Keillor JS; Aterman K
    J Urol; 1987 May; 137(5):894-6. PubMed ID: 2437333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.